Viewing StudyNCT00091559



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00091559
Status: COMPLETED
Last Update Posted: 2017-04-05
First Post: 2004-09-10

Brief Title: Oral SAHA Suberoylanilide Hydroxamic Acid in Advanced Cutaneous T-cell Lymphoma 0683-001
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-02-03
Start Date Type: ACTUAL
Primary Completion Date: 2005-11-23
Primary Completion Date Type: ACTUAL
Completion Date: 2006-03-13
Completion Date Type: ACTUAL
First Submit Date: 2004-09-10
First Submit QC Date: September 13 2004
Study First Post Date: 2004-09-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-03
Last Update Post Date: 2017-04-05
Last Update Post Date Type: ACTUAL